NEUROCRINE BIOSCIENCES INC Increase (Decrease) in Deferred Revenue
NEUROCRINE BIOSCIENCES INC (NBIX) reported Increase (Decrease) in Deferred Revenue of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-02-13
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred revenue for the quarter ending 2016-12-31 was $0.00.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred revenue for the quarter ending 2016-09-30 was $0.00.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred revenue for the quarter ending 2016-06-30 was $0.00.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred revenue for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred revenue for fiscal 2017 was $0.00.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred revenue for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred revenue for fiscal 2015 was $10.23M.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred revenue for fiscal 2014 was $0.00.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-13 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $0.00 derived: sum of 2 quarters · filed 2018-02-13 | $0.00 derived: sum of 3 quarters · filed 2018-02-13 | $0.00 10-K · filed 2018-02-13 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $0.00 derived: sum of 2 quarters · filed 2016-11-02 | $0.00 10-Q · filed 2016-11-02 | $0.00 derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $0.00 10-Q · filed 2016-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-02-13 | $0.00 derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | $0.00 derived: sum of 2 quarters · filed 2018-02-13 | $0.00 derived: sum of 3 quarters · filed 2018-02-13 | $0.00 derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $0.00 derived: sum of 2 quarters · filed 2018-02-13 | $0.00 derived: sum of 3 quarters · filed 2018-02-13 | $10.23M 10-K · filed 2018-02-13 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $0.00 derived: sum of 2 quarters · filed 2016-11-02 | $10.23M 10-Q · filed 2016-11-02 | $10.23M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $10.23M 10-Q · filed 2016-08-03 | $10.23M derived: sum of 3 quarters · filed 2017-02-14 | $10.23M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $10.23M 10-Q · filed 2016-05-05 | $10.23M derived: sum of 2 quarters · filed 2017-02-14 | $10.23M derived: sum of 3 quarters · filed 2017-02-14 | $10.23M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $0.00 derived: sum of 2 quarters · filed 2017-02-14 | $0.00 derived: sum of 3 quarters · filed 2017-02-14 | $0.00 10-K · filed 2017-02-14 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $0.00 derived: sum of 2 quarters · filed 2015-10-29 | $0.00 10-Q · filed 2015-10-29 | -$730.00K derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $0.00 10-Q · filed 2015-07-29 | -$730.00K derived: sum of 3 quarters · filed 2016-02-11 | -$1.46M derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-03-31 | $0.00 10-Q · filed 2015-04-30 | -$730.00K derived: sum of 2 quarters · filed 2016-02-11 | -$1.46M derived: sum of 3 quarters · filed 2016-02-11 | -$2.19M derived: sum of 4 quarters · filed 2016-02-11 |
| 2013-12-31 | -$730.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | -$1.46M derived: sum of 2 quarters · filed 2016-02-11 | -$2.19M derived: sum of 3 quarters · filed 2016-02-11 | -$2.92M 10-K · filed 2016-02-11 |
| 2013-09-30 | -$729.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$1.46M derived: sum of 2 quarters · filed 2014-11-04 | -$2.19M 10-Q · filed 2014-11-04 | -$10.18M derived: sum of 4 quarters · filed 2015-02-09 |
| 2013-06-30 | -$730.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | -$1.46M 10-Q · filed 2014-08-06 | -$9.45M derived: sum of 3 quarters · filed 2015-02-09 | -$17.44M derived: sum of 4 quarters · filed 2015-02-09 |
| 2013-03-31 | -$730.00K 10-Q · filed 2014-05-01 | -$8.72M derived: sum of 2 quarters · filed 2015-02-09 | -$16.71M derived: sum of 3 quarters · filed 2015-02-09 | -$25.73M derived: sum of 4 quarters · filed 2015-02-09 |
| 2012-12-31 | -$7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-09 | -$15.98M derived: sum of 2 quarters · filed 2015-02-09 | -$25.00M derived: sum of 3 quarters · filed 2015-02-09 | -$34.24M 10-K · filed 2015-02-09 |
| 2012-09-30 | -$7.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | -$17.02M derived: sum of 2 quarters · filed 2013-10-29 | -$26.26M 10-Q · filed 2013-10-29 | -$35.49M derived: sum of 4 quarters · filed 2014-02-11 |
| 2012-06-30 | -$9.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | -$18.27M 10-Q · filed 2013-07-26 | -$27.50M derived: sum of 3 quarters · filed 2014-02-11 | -$36.74M derived: sum of 4 quarters · filed 2014-02-11 |
| 2012-03-31 | -$9.24M 10-Q · filed 2013-05-02 | -$18.48M derived: sum of 2 quarters · filed 2014-02-11 | -$27.71M derived: sum of 3 quarters · filed 2014-02-11 | -$36.96M derived: sum of 4 quarters · filed 2014-02-11 |
| 2011-12-31 | -$9.24M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | -$18.48M derived: sum of 2 quarters · filed 2014-02-11 | -$27.72M derived: sum of 3 quarters · filed 2014-02-11 | -$37.03M 10-K · filed 2014-02-11 |
| 2011-09-30 | -$9.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | -$18.48M derived: sum of 2 quarters · filed 2012-10-31 | -$27.79M 10-Q · filed 2012-10-31 | |
| 2011-06-30 | -$9.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-31 | -$18.55M 10-Q · filed 2012-07-31 | ||
| 2011-03-31 | -$9.31M 10-Q · filed 2012-05-02 | |||
| 2010-12-31 | $62.49M 10-K · filed 2013-02-08 | |||
| 2009-12-31 | -$2.91M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |